$ERAS News
Last published 21h ago
- 21h agoERASErasca, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 21h agoERASErasca Reports Third Quarter 2026 Business Updates and Financial ResultsGlobeNewswireERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancers
- 4d agoERASPLNTSPTSMPLAttention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. (NYSE: PLNT); The Simply Good Foods Company (NASDAQ: SMPL); and Sprout Social, Inc. (NASDAQ: SPT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 1w agoERASOIPLNTSPTImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); O-I Glass, Inc. (NYSE: OI); Planet Fitness, Inc. (NYSE: PLNT); and Sprout Social, Inc. (NASDAQ: SPT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 1w agoTNGXERASTango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015GlobeNewswireBOSTON and SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to delivering breakthrough targeted therapies that extend and improve
- 1w agoERASErasca to Present at Upcoming Conferences in NovemberGlobeNewswireSAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 1w agoAARDERASPLNTPRCTAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who purchased
- 2w agoAARDERASPODDPLNTAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who purchased
- 2w agoERASPLNTPRCTSMPLImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. (NYSE: PLNT); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 2w agoAARDERASPSIXSMPLImportant Notice Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Power Solutions International, Inc. (NASDAQ: PSIX); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who purchased
- 3w agoCCBQBTSERASPLNTImportant Notice to Long-Term Shareholders of Coastal Financial Corporation (NASDAQ: CCB); D-Wave Quantum Inc. (NASDAQ: QBTS); Erasca, Inc. (NASDAQ: ERAS) and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Coastal Financial Corporation (NASDAQ:CCB): Grabar Law Office is investigating claims on behalf of shareholders of Coastal Financial Corporation (NASDAQ:CCB). What
- 3w agoAARDERASGPGINUAIAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA , Oct. 21, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who
- 3w agoAARDBACCCBERASAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Bank of America Corporation (NYSE: BAC); Coastal Financial Corporation (NASDAQ: CCB); and Erasca, Inc. (NASDAQ: ERAS): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who purchased
- 4w agoAARDCCBERASPSIXAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who purchased
- 1mo agoAXPCCBERASPLNTImportant Notice to Long-Term Shareholders of American Express Company (NYSE: AXP); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS) and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- American Express Company (NYSE:AXP): What is Happening? Grabar Law Office is investigating claims on behalf of long-term shareholders of American Express Company
- 1mo agoAXPCCBDUOLERASAttention Long-Term Shareholders of American Express Company (NYSE: AXP); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Erasca, Inc. (NASDAQ: ERAS): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 12, 2026 (GLOBE NEWSWIRE) -- American Express Company (NYSE:AXP): Current American Express Company (NYSE:AXP) shareholders who have held American Express shares continuously since prior to June
- 1mo agoAARDCCBERASNUAIAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who purchased
- 1mo agoAARDBBNXERASHUBGImportant Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who
- 1mo agoERASMorgan Stanley 24th Annual Global Healthcare Conference - ERASCA INCEarnings Call TranscriptsGood afternoon everyone, I'm Sean Lyman, Head of US Mid-Cap Biotech Equity Research at Morgan Stanley and welcome to the Morgan Stanley Global Health Care Conference. Before we commence, to make you aware of some certain
- 1mo agoERASMorgan Stanley 24th Annual Global Healthcare Conference - ERASCA INCEarnings Call TranscriptsGood afternoon everyone, I'm Sean Lyman, Head of US Mid-Cap Biotech Equity Research at Morgan Stanley and welcome to the Morgan Stanley Global Health Care Conference. Before we commence, to make you aware of some certain
- 1mo agoERASGPGINUAIPSIXAttention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 2mo agoAARDERASHUBGNUAIAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who
- 2mo agoERASErasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR SymposiumGlobeNewswireOral presentation to share updated monotherapy clinical data for ERAS-0015 including additional patients and longer follow-up, expanding on the previously reported preliminary results from the ongoing AURORAS-1 Phase 1
- 2mo agoERASHUBGPRCTSMPLImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 2mo agoERASErasca to Present at the Morgan Stanley 24th Annual Global Healthcare ConferenceGlobeNewswireSAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 2mo agoERASHUBGHYLNPRCTAttention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 2mo agoERASPODDNUAIPSIXImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ: NEHC)); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Aug. 26, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary
- 2mo agoERASErasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic AdenocarcinomaGlobeNewswireDesignation follows encouraging Phase 1 activity across multiple tumor types including 2L+ KRAS G12X pancreatic cancer Three potentially registration-enabling trials planned across pancreatic and lung cancers
- 3mo agoSPRYBEERASPODDAttention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Aug. 14, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ:SPRY): Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY). What is The
- 3mo agoERASErasca Reports Second Quarter 2026 Business Updates and Financial ResultsGlobeNewswireUpdated ERAS-0015 data in U.S. trial highlighted compelling monotherapy efficacy in 2L+ KRAS G12X PDAC and continued favorable tolerability, as well as further advancement of panitumumab CRC combination ERAS-0015
- 3mo agoERASErasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireSAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 3mo agoERASErasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&DGlobeNewswireSAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 3mo agoERASPODDPSIXPRCTImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 3mo agoERASPODDNUAIPSIXImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ: NEHC)); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, July 29, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) breached their fiduciary duties
- 3mo agoERASThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in Erasca, Inc. Lawsuit - ERASPR NewswireThe Gross Law Firm issues the following notice to shareholders of Erasca, Inc. (NASDAQ: ERAS). Shareholders who purchased shares of ERAS during the...
- 3mo agoERASHUBGPLNTPRIMNotice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Planet Fitness, Inc. (NYSE: PLNT): and Primoris Services Corporation (NYSE: PRIM): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, July 28, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) ("Erasca" or the
- 3mo agoERASPODDPLABNUAINotice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and (NASDAQ: NUAI) (formerly known as New Era Helium (NASDAQ: NEHC)): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA , July 23, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) ("Erasca" or the
- 3mo agoERASPODDPLABVIANotice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and Via Transportation, Inc. (NYSE: VIA): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- ERASCA, INC. (NASDAQ:ERAS): Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ:ERAS) ("Erasca" or the
- 4mo agoERASErasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswireSAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 4mo agoADMACVLTERASHUBGImportant Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) -- ADMA BIOLOGICS, INC. (NASDAQ:ADMA): Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ:ADMA) breached their
- 4mo agoERASErasca Announces Pricing of Upsized Public Offering of Common StockGlobeNewswireSAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 4mo agoERASErasca Announces Proposed Public Offering of $500 Million of Common StockGlobeNewswireSAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with
- 4mo agoERASErasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid TumorsGlobeNewswireAt RDE of 32 mg QD, encouraging monotherapy responses with 57% uORR in 2L+ KRAS G12X pancreatic cancer in U.S. trial and median relative dose intensity of 100% Monotherapy has been generally well-tolerated at RDEs
- 4mo agoEMBCERASHUBGGTMAttention Long-Term Shareholders of Embecta Corp. (NSADAQ: EMBC); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, July 10, 2026 (GLOBE NEWSWIRE) -- EMBECTA CORP. (NASDAQ:EMBC): Grabar Law Office is investigating whether certain officers and directors of Embecta Corp. (NASDAQ:EMBC) ("Embecta" or the
- 4mo agoERASREMINDER: Erasca, Inc. Investors With Significant Losses Must Act By August 10, 2026 – Kirby McInerney LLPGlobeNewswireNEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Erasca, Inc. ("Erasca" or the "Company") (NASDAQ:ERAS) investors of the August 10, 2026 deadline to seek the role of lead
- 4mo agoERASERAS INVESTOR REMINDER: Erasca, Inc. Investors Have Until August 10, 2026 to Seek Lead Plaintiff RoleBusiness WireIf you have suffered a loss on your Erasca, Inc. ("Erasca" or the "Company") (NASDAQ:ERAS) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the
- 4mo agoERASINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Erasca, Inc. (ERAS) to Contact Law FirmGlobeNewswireNEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against the officers and directors of Erasca, Inc.
- 4mo agoEMBCERASNAVNPSIXGrabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Embecta Corp. (NASDAQ: EMBC); Navan, Inc. (NASDAQ: NAVN); and Power Solutions International, Inc. (NASDAQ: PSIX)GlobeNewswirePHILADELPHIA, June 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (NASDAQ:EMBC): Grabar Law Office is investigating whether certain officers and directors of Embecta Corp. (NASDAQ:EMBC) ("Embecta" or the
- 5mo agoERASErasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; HBSS Investigating Intellectual Property Questions Regarding Lead AssetPR NewswireInvestors in Erasca, Inc. (NASDAQ: ERAS) saw the price of their shares tank $9.25 (-48%) on April 28, 2026 after the company announced that it is...
- 5mo agoERASErasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; HBSS Investigating Intellectual Property Questions Regarding Lead AssetPR NewswireInvestors in Erasca, Inc. (NASDAQ: ERAS) saw the price of their shares tank $9.25 (-48%) on April 28, 2026 after the company announced that it is...